Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

http://www.wikidata.org/entity/Q28283880

about

The Combination of Arginine Deprivation and 5-Fluorouracil Improves Therapeutic Efficacy in Argininosuccinate Synthetase Negative Hepatocellular Carcinoma.Expression profile and down-regulation of argininosuccinate synthetase in hepatocellular carcinoma in a transgenic mouse model DNA methylation, microRNAs, and their crosstalk as potential biomarkers in hepatocellular carcinoma.BRAF inhibitor resistance enhances vulnerability to arginine deprivation in melanoma.Reduced argininosuccinate synthetase expression in refractory sarcomas: Impacts on therapeutic potential and drug resistance.Basic amino acids and dimethylarginines targeted metabolomics discriminates primary hepatocarcinoma from hepatic colorectal metastases Arginine and the metabolic regulation of nitric oxide synthesis in cancer

P2860

Q33838601-DE16ED8A-F271-4AF3-8395-5ED3ED4C4C85 Q35021230-35D3CAE4-0C8A-4724-B9EB-9EC1C667FE25 Q35197356-991F7AC8-BB78-4E67-A58B-8EF965903E5A Q37109564-D354DE61-AC26-4B4F-B0B2-F261A951D374 Q37688620-9A51B8C4-E94C-4C69-A830-B6DF8AA5B652 Q57781463-947624EE-B97D-4BF1-9ECD-24D2E7CB6E9D Q58798459-88545545-3312-4DD4-9106-E9F078C55F7A

P2860

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

http://www.wikidata.org/entity/Q28283880

description

2013 nî lūn-bûn

@nan

2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@ast

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@en

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@nl

type

label

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@ast

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@en

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@nl

prefLabel

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@ast

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@en

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@nl

P1433

Q28283880-646D0233-D0D2-4898-81B0-31FA08BF2D4E

P1476

Q28283880-9177004F-3246-4794-984F-2216BD901A27

P2093

Q28283880-0AABEBB1-CF53-4CC8-8455-2F29C028257D

Q28283880-4B1432B2-82A3-435A-9231-FF32EE971477

Q28283880-C78A2C6B-DBFC-470E-83CB-1B2608A4B684

Q28283880-CEE596FF-427E-4AA7-9E0D-6CEC5C0C616C

Q28283880-E1BD22EB-21D3-442A-94AA-6980C5DB492F

Q28283880-F8AA2DF3-3D43-4197-A009-5924FF3616B0

P2860

Q28283880-03A035A3-3B4A-442C-AFFF-BF359F0658F9

Q28283880-0F36DFB7-ACE6-42FF-A2F2-348BF70AAAF0

Q28283880-233C32DB-EEF7-4116-A7D4-B724C667BD97

Q28283880-31D2FF28-8E00-4787-9A98-15A2D3F28E82

Q28283880-3B3C546A-3076-48CC-B811-F255050F939D

Q28283880-66439957-DFE8-4B67-9809-A2A7792F6D86

Q28283880-72A12427-F4AC-4335-B4D6-A40983E1001D

Q28283880-80333F49-3564-4BCA-9381-D4624E839D86

Q28283880-A375A8B8-9CCB-407D-9FAC-38222EE5609D

Q28283880-B7BB3EA3-5BA7-4B08-935E-AF37B82BC62C

P304

Q28283880-3835E2A8-E6AB-4DC9-9732-95469610BCDD

P31

Q28283880-CC1E8598-7A64-45B8-89B9-BE75EC83DB82

P3181

Q28283880-150DDEAE-7EA8-4801-9C00-325F49A8C1D2

P356

Q28283880-188F4424-3D4F-4E43-B324-0E065A7C3E4C

P407

Q28283880-1DC9E30E-8B89-4420-A9C2-FE99272E1950

P433

Q28283880-59A19698-4CFF-4B63-8CDC-36F708ABD310

P478

Q28283880-853ACE64-88C9-48C6-8044-ACA5C346BD1E

P577

Q28283880-2985B0A7-A730-4F22-8FCB-412C674082CA

P698

Q28283880-8DCF7313-DE17-461D-A970-75A92DBEE975

P3181

P356

P1433

Journal of Gastroenterology and Hepatology

P1476

Expression of argininosuccinate synthetase in patients with hepatocellular carcinoma

@en

P2093

Li Li

http://www.w3.org/2001/XMLSchema#string

Lina Wu

http://www.w3.org/2001/XMLSchema#string

Ming Lin

http://www.w3.org/2001/XMLSchema#string

Ruizhao Qi

http://www.w3.org/2001/XMLSchema#string

Shucong Meng

http://www.w3.org/2001/XMLSchema#string

Zebin Mao

http://www.w3.org/2001/XMLSchema#string

P2860

Arginine metabolism: nitric oxide and beyond

Pegylated arginine deiminase: a novel anticancer enzyme agent.

Updated treatment approach to hepatocellular carcinoma.

Arginine deprivation as a targeted therapy for cancer.

Hepatocellular carcinoma: A global view.

Canavanine augments proapoptotic effects of arginine deprivation in cultured human cancer cells.

In vivo loss of expression of argininosuccinate synthetase in malignant pleural mesothelioma is a biomarker for susceptibility to arginine depletion.

Role of polyamines in arginine-dependent colon carcinogenesis in Apc(Min) (/+) mice.

Incidence and distribution of argininosuccinate synthetase deficiency in human cancers: a method for identifying cancers sensitive to arginine deprivation.

Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.

P304

365-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3193765

http://www.w3.org/2001/XMLSchema#string

P356

10.1111/JGH.12043

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23339388

http://www.w3.org/2001/XMLSchema#string